9999999997-12-001081.txt : 20120221
9999999997-12-001081.hdr.sgml : 20120220
20120221163654
ACCESSION NUMBER: 9999999997-12-001081
CONFORMED SUBMISSION TYPE: CT ORDER
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20120221
DATE AS OF CHANGE: 20120221
20120221
20120221
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVI BIOPHARMA INC
CENTRAL INDEX KEY: 0000873303
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930797222
STATE OF INCORPORATION: OR
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: CT ORDER
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14895
FILM NUMBER: 12627287
BUSINESS ADDRESS:
STREET 1: 3450 MONTE VILLA PARKWAY
STREET 2: SUITE 101
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 425-354-5038
MAIL ADDRESS:
STREET 1: 3450 MONTE VILLA PARKWAY
STREET 2: SUITE 101
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIVIRALS INC
DATE OF NAME CHANGE: 19970123
CT ORDER
1
filename1.pdf
begin 644 filename1.pdf
M)5!$1BTQ+C4-)>+CS],-"C0T(#`@;V)J#3P\+TQI;F5AF4@-38F)D$&!@
M8F#R`A(,4X`$XPT@P9(()-BU@<0G)08F1H;=(%D&1G3B/^.,/P`!!@"T10;D
M#0IE;F1S=')E86T-96YD;V)J#7-T87)T>')E9@T*,`T*)25%3T8-"B`@("`@
M("`@#0HU-B`P(&]B:@T\/"]#(#8Y+T9I;'1E8F!@8&%@8(IF``*>-@94P,@`
MDN5H0!9C@6(&AAL,W`Q7!E+U!A9V4^/@UE;F1O8FH--#<@,"!O8FH-/#PO1FEL=&5R+T9L871E
M1&5C;V1E+T9IV;2C&Q,"B$HP1U99\6NVCZ^652[LF/7Y4_VM=D5]5NR
M71>[DI,%#*3_,O^\(-.\;\M^N>'73;LKMJ2Z&8K10O"KOMA6R\MZO2V9X/.^
MW'UCF>"+Q_N27+'8MKKOFY9_=SUHG5U<0(?8,;H'SAQ\]5K)H'THJ*=0%F5?]IKNU-F/_
M$M((II2"LX3Q@.M"9/"-MB0;;`BRI3KXXRKM/N8YH"_Y0PX/#;.8RX19*6&P
M+('D)('93$E&4`U9'FR9DQ'>#V-11KNWY9#?RZBGNJ$&ZC?-J2Z2\4V`'*^A
MY[AV)]LC??L:XS.A^IR,.36X-M$I4\3KK%/$NX9
M[OU:UM7_,^L:^`7[4:"WFD44%=ZD%:^FW9#'BCU`GRL1:#-0I'MKODCD"WJO
M(*,MT"E^>S_WCN(\U$B<-.9=DR6A,.-8C7C7K;$^Q#@Y<[*WAQA';-XVYEV5
MPZ.5@E8CQ5'>#3=PDG<'+D7BQ99&Q!NBQL0[""]E7ADQK[;$GGX2O.XIYC5:
M'#*O^I-Y371)8X0;]']E#VHD0@@Z,N-8K!^1,?P?_M38HL]?4^^I/)YZW:0$
M[&.`>G\+,`!P&WLM#0IE;F1S=')E86T-96YD;V)J#30X(#`@;V)J#3P\+T9I
M;'1ED_@^D[U*Q6$WHUESF"BX"EDS.2
MTMA-4U$:BDDI8NGJC)*GE=(?STCXQ@'NNAY+E\PIG[XPQ^-)HOU:#1ZL#W9@
MS>!W:TLKG4[@B=W;CK#2$3RFTWO[S_07V`DLXJ)^Q),8G\YY%VC;9%*2GGH`
MV\+G45@W#I9":VH[@37^<'=K.YZ5X@L]T30)L-%LPNCU#UNXUOAGV_&MT>PG
MN]1EXU]QYIWMQ#!(I4Z:--`K21QP]L;6PCKT?:M!2[V#`]'
M?)@_HY5O3(HADZZ09"3BL>B+4V3B!`FIC"CATRIQ;V@E=X.ZL[3ANPD%Z(YA
MK.Y&D%?7FE4AIA`RFE4AG-W8B?JD%&NRH[<4:IJX@X\BL$;T@A'7PLWP2I^[
M25\0DKX=@;;7`.I,;X;,$@BF+8L!3V3=X(EU7P2ZYJHA]RZOJO#9Q>9H3*LS
MBB^&EPG;D5:"@X>#W[(&F9117]2$H2O,N@S:Z.G(&T)R?!XT$#V"W/VN*D98
M[!HCL$&?\O<(]76%[JTM/&L^9"2XP_DEP)^3ZPD7O5`7LF[_LKN&X)R01Z)3
M@.1@A@.6(IN!^SEGY(GEN@*7#+BK2&OL:]C((@0GW)@_XH^556@1+J8?JK[^\\7XB@
MUE[*/@:ESB.UMM?C2]CI,67\-&2`:6\1$H"9R$`&4+&>(UJ>;0\0`Y-SR-!0
M$0R)[RK4J&4?K`,BZK@@&=*AU0HS8))7#!?:T;C?9T8*5\.YPLSD.W;(8O.(FOQ=9\5D%$-5SB
MF2AEHU=24X&U):6--L(V!<,%OF*ZT'IVA%EM%?\SU'XN5]BR8EU^@V[K*36<
MV2QP*-K-\T!AC;CHDJ.O*\I'29=+7T>U0'SD"!4V9S?MAF&8[\'**?J$B#*-
MPB6LEWG21G]3!1XUG#B1CP<5\\QLO67;\;PF.>6[JK0>+**9SP@#TVHF]/UA#VBRE;WZ@O,VW&(1'HM$5#H^K=@_`0X':#U?[D6$O>53'"3AC
MB?`BQ\;G"QPK>J[AKJH/JHK\QPWCS-Y4AA':%;K>Z\6(GZ&QJ.K^9DM=+X9&
MQ'?SB'3QX',I]X1LJ@X%\LW!%B\HH$\P'$O-;$,`0OR0LLJX]%KGKKG^_J)R
MUT);J'0Z4P94J!L%%Q+1OE&M@L<=I%0U0RR)H4%]%34B.J8(ZPG"F3=B>I8X
MZ<.:"))59GQ+MI005-.M\XA2RT[A$O$!YC@]Q@2
M/L93"6=!(#]:L.[BHPTC/?KT6.*BYO'$+@U^II$PJAU0_M*:Y.:>QHZ?-RH)
M$+0RIN6VV=J4!J-HE3VJ#E:EIRIGEY.`BF>NM@\E]V#MCXMF'\LH9:I&5I7?
M2YW#W)0:JSHD9TR%#NS30+M9U?H3ZI;+#AEJ?Z5HF66/*^5H`R&:>#MAP>]H
MH4Q^+>:DF9FC6?[%;K;)RO2:IA?E)C`@P+Q2TS'X+95^P,K*,80'FU%07NM_IKIOIUHLE;%I%D=.XQH9(XON2%U`_VRR[-?D"
M2JKS3JWS%INM,6$X@1BIW22BJNG]QZB=[%?4H_;4EI8;Q-1363]8`9A`:EFO
M6LY`U_%[.U1UUY-P2[O8H:3;Z%"7_U2;GD+:OC81AD"%4Z^G!15H"<5'PN8:
M[A"0V)[N'JI.$_+`Z]NCK"Y:2K:UQX:R>6ENP:J-89](Q[BLW0K;ED\`T/3[
M&SL^A4.\VI2MB9HE_LK&V,Q\S(5I0,-&JR^(TOYW3AZR_1$5U$UB;@XCK-`'
MA$C?O'(=#:$80O`XKC,$D6%F*)W@,:]87M]$C@I#Y*9&&9%W&1FLS5#?0%^5
M![BD%SK5I3?B272Q.OS.^:TC$EP6Z5[S.B+1N8/B?W\Q8,2'N('%:SM1?$R:;.
MK_,,1\1_I&Y&1QSH=D!<_)BUMA=R/^K=7HUK?92]@";//8V#:3KX5X`!`/]X
M&J0-"F5N9'-TY!@9$1FEP'Z>@8V!F0$,$I.+"QP#`GQ`[+S\O%0/#M&@,CB+ZL
M"S(+4QXO8$TN*"H!T@>`V"@EM3@92'\!XLSRD@*@.&,"D"V2E`UF@]2)9(<$
M.0/9'4`V7TEJ!4B,P3F_H+(H,SVC1,'0TM)2P3$E/RE5(;BRN"0UMUC!,R\Y
MOZ@@ORBQ)#4%J!9J!PCPNQ`P8A0[
MCQ!#@.32HC(HDY')F($!(,``2<8X+PT*96YDW))!;MLP$$6O,C>@.$-*
M%!`82-,&*(*ZANVN@BY4AW"$)I*@R$!R^WYIG+1==++O1A_DC![)1Y944$5)
M*)$P4TT2//F"HE3D/54QDF>J$@(]'A$H!42D5"%*J@M$1;4@$M4EHJ:ZCL0%
M0(R<@>``[XM4$@O(^(,#,B1""X8U<8FEL#1C9<8N."$K)JZQ=B$DX(D$$O`$
MRPAX4I>8-YEP$O`B-C&?)$9/`EY,3`)>B=,$\,H0:#YPB;-<
M7+@;N"AHZS;-F+MI/^8,+W]/K//S=)-?R+MM_Y"_-`.#DO;
MMN^GU6I&WD(C&F:-2XA&T(@:I4:ED306\*QQ":6P4E@IK!16"BN%E<)*8:6(
M4D0IHA11BBA%E")*$:6(4D0I02EAH7QW&UIZW<[M\D&/NSX]/MW.%[]T+%.7
M7==/S=3VG=L-3>>N[IMQOY<
M0^GOT>?NH>WR[KZ!]G/WU],TS^DJN(KV9^Y/TWEX^O%T&-OA;3CD\<^)/:[U
M0__L+K&U;]U='M](J]7_>X/+DR]PC^=G?Z3P>J,;?;UXYU:5S:J8U6!6HUDM
MS6IE5I-9K6T;[\BR;7E;E[=]>5N8MXUY6YFWG7E;FK>ML6V-WWECMC6VK;%M
MC6UK;%MCVQK;UMBV)O^T]DN``0!5K+VR#0IE;F1S=')E86T-96YD;V)J#3(@
M,"!O8FH-/#PO3&5N9W1H(#0Q.3`O4W5B='EP92]834PO5'EP92]-971A9&%T
M83X^G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E
M.FYS.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835`@0V]R92`T+C(N,2UC,#0S
M(#4R+C,W,C&UL;G,Z6YT87@M;G,C(CX*("`@("`@/')D9CI$97-C&UL;G,Z>&UP/2)H='1P.B\O;G,N
M861O8F4N8V]M+WAA<"\Q+C`O(CX*("`@("`@("`@/'AM<#I-;V1I9GE$871E
M/C(P,3(M,#(M,C%4,38Z,S$Z-#DM,#4Z,#`\+WAM<#I-;V1I9GE$871E/@H@
M("`@("`@("`\>&UP.D-R96%T941A=&4^,C`Q,BTP,BTR,50Q-CHS,3HT.2TP
M-3HP,#PO>&UP.D-R96%T941A=&4^"B`@("`@("`@(#QX;7`Z365T861A=&%$
M871E/C(P,3(M,#(M,C%4,38Z,S$Z-#DM,#4Z,#`\+WAM<#I-971A9&%T841A
M=&4^"B`@("`@("`@(#QX;7`Z0W)E871O&UP34TZ&UP34TZ
M&UL.FQA;F<](G@M9&5F875L="(^(#PO&UL.FQA;F<](G@M9&5F875L
M="(O/@H@("`@("`@("`@("`\+W)D9CI!;'0^"B`@("`@("`@(#PO9&,Z9&5S
M8W)I<'1I;VX^"B`@("`@("`@(#QD8SIC&UL;G,Z<&1F
M/2)H='1P.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O(CX*("`@("`@("`@/'!D
M9CI02`Y+C`\+W!D9CI07!E+T]B:E-T;3X^+[=^$*@G<4NTPYXME)"*J&4E,M(SN.I6$R$F'Q77ER7
MA(5V[)3MCOH&Q.*99!42NR"9(-S#\/)A/#FB^4^>"$U?@C<-%C"*[&`+TC1X
M5`1ACCV5X!E;63`_CI*1C,9!7URA=/[K;%T+G`5I^A9@`#[+3$H-"F5N9'-T
M